A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro
Hongxiang Wei,1,* Jinyuan Chen,2,* Shenglin Wang,1,* Feihuan Fu,3 Xia Zhu,1 Chaoyang Wu,1 Zhoujie Liu,4 Guangxian Zhong,1 Jianhua Lin1 1Department of Orthopaedics, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350004, People’s Republic of China; 2Department of Centrala...
Main Authors: | Wei H, Chen J, Wang S, Fu F, Zhu X, Wu C, Liu Z, Zhong G, Lin J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-11-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/a-nanodrug-consisting-of-doxorubicin-and-exosome-derived-from-mesenchy-peer-reviewed-article-IJN |
Similar Items
-
Exosomes Secreted by Adipose-Derived Mesenchymal Stem Cells Foster Metastasis and Osteosarcoma Proliferation by Increasing COLGALT2 Expression
by: Yan Wang, et al.
Published: (2020-05-01) -
The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma <it>in vitro</it>
by: Marley Kevin, et al.
Published: (2013-01-01) -
Doxorubicin Delivered Using Nanoparticles Camouflaged with Mesenchymal Stem Cell Membranes to Treat Colon Cancer
by: Liu Y, et al.
Published: (2020-04-01) -
In Vitro Delivery and Controlled Release of Doxorubicin for Targeting Osteosarcoma Bone Cancer
by: Tengku Azmi Tengku Ibrahim, et al.
Published: (2013-08-01) -
Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma
by: Martina Godel, et al.
Published: (2020-06-01)